Clinicopathologic characteristics of immune colitis in melanoma patients treated with combination ipilimumab and anti-PD1 (IPI+PD1) and PD1 monotherapy — Kazi Nahar (2019) | RDL Network
Clinicopathologic characteristics of immune colitis in melanoma patients treated with combination ipilimumab and anti-PD1 (IPI+PD1) and PD1 monotherapy
Helen Dearden, Lewis Au, Daniel Ying Wang, Lisa Zimmer, Zeynep Eroglu, Jessica L. Smith, Marcello Curvietto, Chloe Khoo, Victoria Atkinson, Serigne Lo, Alexander Guminski, Georgina V. Long, Shahneen Sandhu, Paolo A. Ascierto, Matteo S. Carlino, Douglas B. Johnson, James Larkin, Alexander M. Menzies
Kazi Nahar, Robert V. Rawson, Tasnia Ahmed, Stephen Tattersall, Neomal S. Sandanayake, Christopher J. Kiely, Serigne Lo, Matteo S. Carlino, Umaimainthan Palendira, Richard A Scolyer, Georgina V. Long, Alexander M. Menzies
Inês Pires da Silva, Jordan W. Conway, Jarem Edwards, Felix Marsh‐Wakefield, Camelia Quek, Angela L. Ferguson, Peter Johnansson, Matteo S. Carlino, Alexander Menzies, James S. Wilmott, Umaimainthan Palendira, Richard A Scolyer, Georgina V. Long
Ines Esteves Domingues Pires Da Silva, Tasnia Ahmed, Serigne Lo, Rajat Rai, Jessica L. Smith, John Park, C. Nabhan, Richard A Scolyer, Matteo S. Carlino, Jennifer L. McQuade, Douglas B. Johnson, Georgina V. Long, Alexander M. Menzies
Lauren Brown, Alison M. Weppler, Prachi Bhave, Clara Allayous, James R. Patrinely, Patrick A. Ott, Shahneen Sandhu, Andrew Haydon, Célèste Lebbé, Douglas B. Johnson, Georgina V. Long, Alexander Menzies, Matteo S. Carlino
Discussion(0)
No comments yet. Be the first to comment.